Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that hair loss in women can be caused by various factors and is managed with specific treatments like medication, therapy, and lifestyle changes.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Effective treatments for excessive body hair in women include drugs that block androgens, sometimes combined with oral contraceptives.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Hair transplantation has improved with techniques that increase graft survival and patient satisfaction for more natural results.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Genetic factors could lead to personalized treatments for hair loss.

Multiple treatments work best for hair loss.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

Topical cetirizine 1% increases hair density and may be a promising treatment for hair loss.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.